CompoAtlas

Petit BB - Shimmering

Natural health product licensed in Canada

Other names
Holika Holika Petit BB Shimmering SPF 45
Licence holder
K-House Trading Inc.
NPN or DIN-HM
80040440
Status
Active licence
Licence date
28 February 2013
Revision date
Not provided
Form
Crème
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal composition not provided.

Non-medicinal ingredients

Sulfate de magnésium, PEG-10 Dimethicone, Dipropylene glycol, Hydrate d'alumina, Extrait de Chrysanthemum x morifolium, Triethanolamine, Mica, Eau purifiée, Rosa hybrid flower extract, Polymère croisé de diméthicone/vinyl diméthicone, Extrait de lilas, Ethylhexyl Methoxycinnamate, Parfum, Pearl powder, Talc, (p)-hydroxybenzoate de butyle, Diméthicone, Hexyl laurate, Extrait de fleur de lilium candidum, Octisalate, Hectorite de Distérdimonium, Cétyl Diméthicone, Phénoxyéthanol, Oxydes de fer, Barium Sulfate, Bisdisulizole disodium, Extrait de fleur de Nelumbo nucifera, Méthicone, (p)-hydroxybenzoate de méthyle, (p)-hydroxybenzoate de propyle, Glycérine, Aluminum Stearate, Cyclopentasiloxane, Troxérutine, Lavender Flower Extract

PopulationAgeQuantity per servingFrequency
Adultes et enfantsmaximum: 6 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

SPF 45. Sunburn protectant. Helps prevent or protects from subnack. Sunscreen. Filters/screens harmful UVA/UVB rays.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Source

Official Health Canada record, licence 80040440

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line